Perceptive Advisors’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $15.9M | Buy |
+6,993,646
| New | +$15.9M | 0.59% | 40 |
|
2021
Q3 | – | Sell |
-1,640,957
| Closed | -$10.4M | – | 143 |
|
2021
Q2 | $10.4M | Sell |
1,640,957
-513,017
| -24% | -$3.25M | 0.13% | 107 |
|
2021
Q1 | $16.7M | Sell |
2,153,974
-423,069
| -16% | -$3.27M | 0.21% | 82 |
|
2020
Q4 | $16.9M | Hold |
2,577,043
| – | – | 0.18% | 93 |
|
2020
Q3 | $17.1M | Hold |
2,577,043
| – | – | 0.25% | 70 |
|
2020
Q2 | $21.5M | Sell |
2,577,043
-676,880
| -21% | -$5.64M | 0.35% | 57 |
|
2020
Q1 | $25M | Hold |
3,253,923
| – | – | 0.65% | 39 |
|
2019
Q4 | $27M | Hold |
3,253,923
| – | – | 0.54% | 42 |
|
2019
Q3 | $24M | Buy |
3,253,923
+100,000
| +3% | +$738K | 0.65% | 36 |
|
2019
Q2 | $35.4M | Sell |
3,153,923
-20,000
| -0.6% | -$224K | 0.81% | 32 |
|
2019
Q1 | $34.1M | Buy |
3,173,923
+262,208
| +9% | +$2.82M | 0.96% | 30 |
|
2018
Q4 | $43.6M | Buy |
2,911,715
+250,000
| +9% | +$3.74M | 1.66% | 17 |
|
2018
Q3 | $49.2M | Buy |
2,661,715
+740,000
| +39% | +$13.7M | 1.32% | 24 |
|
2018
Q2 | $43.9M | Sell |
1,921,715
-287,097
| -13% | -$6.56M | 1.15% | 28 |
|
2018
Q1 | $62.8M | Sell |
2,208,812
-281,569
| -11% | -$8.01M | 1.76% | 16 |
|
2017
Q4 | $52.6M | Buy |
2,490,381
+1,100,000
| +79% | +$23.2M | 1.74% | 14 |
|
2017
Q3 | $25.3M | Hold |
1,390,381
| – | – | 0.97% | 23 |
|
2017
Q2 | $21.6M | Sell |
1,390,381
-140,278
| -9% | -$2.17M | 1.08% | 27 |
|
2017
Q1 | $26.4M | Buy |
1,530,659
+606,896
| +66% | +$10.5M | 1.51% | 20 |
|
2016
Q4 | $10.2M | Buy |
+923,763
| New | +$10.2M | 0.72% | 34 |
|
2016
Q3 | – | Sell |
-742,021
| Closed | -$7.58M | – | 196 |
|
2016
Q2 | $7.58M | Hold |
742,021
| – | – | 0.53% | 41 |
|
2016
Q1 | $9.57M | Buy |
742,021
+99,974
| +16% | +$1.29M | 0.84% | 26 |
|
2015
Q4 | $13.4M | Buy |
+642,047
| New | +$13.4M | 0.99% | 25 |
|